On Target: Pinpointing Prostate Cancer | Unravelling the key to a more accurate diagnosis pathway
Prostate cancer is the 2nd most commonly occurring cancer in men and in New Zealand, it is the second deadliest. But Dr. Daniel Cornfeld, Mātai Clinical Lead & Head of Radiology at Te Whatu Ora Tairāwhiti (Gisborne Hospital), is leading a study that could transform the prostate cancer diagnosis pathway in the country, making it more accurate by identifying more significant cancers and fewer insignificant cancers. This project is expected to have an immediate positive impact in Tairāwhiti Gisborne, especially for Māori men, who are statistically most at risk and make up approximately 40% of the male population in the region.
#GEHealthcare
Subscribe to GE Healthcare: https://invent.ge/3ipZ7wI
Learn more about GE Healthcare
Website: http://www.gehealthcare.com
Facebook: https://www.facebook.com/GEHealthcare
Twitter: http://twitter.com/gehealthcare
LinkedIn: http://www.linkedin.com/company/gehea...
About GE Healthcare:
As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.
With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.
We embrace a culture of respect, transparency, integrity and diversity.
On Target: Pinpointing Prostate Cancer | Unravelling the key to a more accurate diagnosis pathway
http://www.youtube.com/gehealthcare
-
Category
No comments found